Recursion Pharmaceuticals (RXRX) Q1 2026 Earnings

25FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.52
-0.41
-0.31
-0.21

Details

Expected EPS
-0.301429
Actual EPS
-0.21
Surprise EPS
0.09
Surprise Percent
+30.33%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.21 per share for Q1 2026.

0 Comments

Share your thoughts